KR940007058A - 글리코실화 사이토킨 - Google Patents

글리코실화 사이토킨 Download PDF

Info

Publication number
KR940007058A
KR940007058A KR1019930019661A KR930019661A KR940007058A KR 940007058 A KR940007058 A KR 940007058A KR 1019930019661 A KR1019930019661 A KR 1019930019661A KR 930019661 A KR930019661 A KR 930019661A KR 940007058 A KR940007058 A KR 940007058A
Authority
KR
South Korea
Prior art keywords
sugar
modified
interferon
group
cytokine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1019930019661A
Other languages
English (en)
Korean (ko)
Inventor
나오루 하마구찌
준 사또
가즈히로 도껜
Original Assignee
다께다 구니오
다께다야꾸힝고오교오 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 다께다 구니오, 다께다야꾸힝고오교오 가부시끼가이샤 filed Critical 다께다 구니오
Publication of KR940007058A publication Critical patent/KR940007058A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
KR1019930019661A 1992-09-24 1993-09-24 글리코실화 사이토킨 Withdrawn KR940007058A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP92-254962 1992-09-24
JP25496292 1992-09-24
JP8892093 1993-04-15
JP93-88920 1993-04-15

Publications (1)

Publication Number Publication Date
KR940007058A true KR940007058A (ko) 1994-04-26

Family

ID=26430256

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930019661A Withdrawn KR940007058A (ko) 1992-09-24 1993-09-24 글리코실화 사이토킨

Country Status (9)

Country Link
US (1) US5643564A (https=)
EP (1) EP0589378B1 (https=)
KR (1) KR940007058A (https=)
CN (1) CN1087916A (https=)
AT (1) ATE229981T1 (https=)
CA (1) CA2106821A1 (https=)
DE (1) DE69332576T2 (https=)
PH (1) PH31582A (https=)
TW (1) TW263437B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0770195A (ja) * 1993-08-23 1995-03-14 Yutaka Mizushima 糖修飾インターフェロン
IL116730A0 (en) * 1995-01-13 1996-05-14 Amgen Inc Chemically modified interferon
DE69636112T2 (de) * 1995-08-30 2006-12-14 Toray Industries, Inc. Verfahren zum testen von myocarditis und cardiomyopathie
AUPP660698A0 (en) * 1998-10-21 1998-11-12 University Of Queensland, The A method of protein engineering
AR078117A1 (es) 2006-06-20 2011-10-19 Protech Pharma S A Una muteina recombinante del interferon alfa humano glicosilado, un gen que codifica para dicha muteina, un metodo de produccion de dicho gen, un metodo para obtener una celula eucariota productora de dicha muteina, un metodo para producir dicha muteina, un procedimiento para purificar dicha muteina
CN103429226A (zh) * 2011-03-02 2013-12-04 森苏林公司 囊泡组合物
AU2018300069C1 (en) 2017-07-11 2025-11-20 Synthorx, Inc. Incorporation of unnatural nucleotides and methods thereof
WO2019028419A1 (en) 2017-08-03 2019-02-07 Synthorx, Inc. CYTOKINE CONJUGATES FOR THE TREATMENT OF PROLIFERATIVE AND INFECTIOUS DISEASES
KR20260039812A (ko) 2019-02-06 2026-03-20 신톡스, 인크. Il-2 콘쥬게이트 및 이의 사용 방법

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4386026A (en) * 1981-04-20 1983-05-31 Merck & Co., Inc. Cell-specific glycopeptide ligands
EP0098110B1 (en) * 1982-06-24 1989-10-18 NIHON CHEMICAL RESEARCH KABUSHIKI KAISHA also known as JAPAN CHEMICAL RESEARCH CO., LTD Long-acting composition
JP2514950B2 (ja) * 1986-03-10 1996-07-10 エフ・ホフマン―ラ ロシユ アーゲー 化学修飾蛋白質，その製造法および中間体
JPS63152393A (ja) * 1986-07-03 1988-06-24 Takeda Chem Ind Ltd グリコシル誘導体
NL194729C (nl) * 1986-10-13 2003-01-07 Novartis Ag Werkwijze voor de bereiding van peptidealcoholen via vaste fase.
US5162503A (en) * 1987-05-19 1992-11-10 Hoffmann-La Roche, Inc. Purification of interleukin-2 by receptor-affinity chromatography
US4829690A (en) * 1987-06-26 1989-05-16 Andros Theodore A Credit card chain holder
JPH01102099A (ja) * 1987-10-14 1989-04-19 Toray Ind Inc 生理活性を有する糖タンパク質
JPH01102098A (ja) * 1987-10-14 1989-04-19 Toray Ind Inc 糖鎖修飾糖タンパク質
US4902502A (en) * 1989-01-23 1990-02-20 Cetus Corporation Preparation of a polymer/interleukin-2 conjugate
JPH03106900A (ja) * 1989-09-20 1991-05-07 Toray Ind Inc 糖鎖修飾ヒトインターフェロン集合体
JPH085914B2 (ja) * 1990-02-16 1996-01-24 株式会社ディ・ディ・エス研究所 グリコシル−蛋白誘導体
US5096816A (en) * 1990-06-05 1992-03-17 Cetus Corporation In vitro management of ammonia's effect on glycosylation of cell products through pH control
JPH0770195A (ja) * 1993-08-23 1995-03-14 Yutaka Mizushima 糖修飾インターフェロン

Also Published As

Publication number Publication date
TW263437B (https=) 1995-11-21
ATE229981T1 (de) 2003-01-15
DE69332576D1 (de) 2003-01-30
EP0589378B1 (en) 2002-12-18
EP0589378A2 (en) 1994-03-30
PH31582A (en) 1998-11-03
EP0589378A3 (en) 1995-02-22
CN1087916A (zh) 1994-06-15
CA2106821A1 (en) 1994-03-25
DE69332576T2 (de) 2003-11-20
US5643564A (en) 1997-07-01

Similar Documents

Publication Publication Date Title
DE69219782T2 (de) Verwendung eines thymosins bei der behandlung von hepatitis c
SE8402560L (sv) Farmaceutisk komposition
LU91498I2 (fr) Etanercept et ses dérivés pharmaceutiquement acceptables.
MX166499B (es) Interferon recombinante inmune humano y composicion farmaceutica que lo incluye
EP1394256A3 (en) HCV genomic sequences for diagnostics and therapeutics
KR910004801A (ko) 인간 gp130 단백질
DE69014474D1 (de) Antikörper gegen TNF-Bindungsprotein I und deren F(ab)-Fragmente.
AU7933891A (en) Process for enhancing the resistance of aquatic animals to disease
ATE174382T1 (de) Retrovirus aus der hiv-gruppe und dessen verwendung
KR940007058A (ko) 글리코실화 사이토킨
DE69024104D1 (de) Polypeptide und Polypeptidanaloge mit inhibitorischer Aktivität gegenüber menschlicher Elastase
KR880012760A (ko) 이작용성 단백질
ATE44649T1 (de) Glykosylierte insulinabkoemmlinge.
DK0537166T3 (da) Vandopløselige polypeptider med stor affinitet for alfa og beta-interferon
KR890008086A (ko) 사이클로헥산 유도체
EP0285061A3 (de) Cyclische Peptide und deren Herstellung
KR910000778A (ko) 에토포시드의 아실화 유도체
KR900700124A (ko) 흑색종 치료용 il-2 및 dtic의 치료 조성물
ES2080060T3 (es) Proteinas que tienen actividad de union a interferon-gamma.
IT8347557A1 (it) Polipeptide avente attività di interferon, composizione che lo contiene o procedimento di preparazione.
DE3773295D1 (de) Homogene rekombinante immun-interferon-fragmente und diese enthaltende pharmazeutische zusammensetzungen.
KR910700259A (ko) T-세포 인지성 펩티드 변형에 의해 면역반응에 영향을 주는 방법
EP0365020A3 (en) Resin composition and its use
KR880002542A (ko) 항종양제
IE871358L (en) Interferon for carcinoma

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

PC1203 Withdrawal of no request for examination

St.27 status event code: N-1-6-B10-B12-nap-PC1203

WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid
PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000